Medications
AstraZeneca wins US approval for lymphoma drug
U.S. regulators have approved a new treatment for people with a rare form of non-Hodgkin lymphoma.
Oct 31, 2017
0
0
Cancer Lymphoma
Oncology & Cancer
Scientists identify genetic drivers of common lymphoma
An international team of scientists has pinpointed the genetic drivers of diffuse large B-cell lymphoma—the most common type of blood cancer—and determined the genes' clinical significance. The study, published in the ...
Oct 31, 2017
0
17
Surgery
Rare cancer linked with textured breast implants may be underreported, misunderstood
A rare cancer in patients with breast implants may be on the rise, but not all patients and physicians may be aware of the risks associated with the procedure, according to a group of Penn State College of Medicine researchers.
Oct 18, 2017
0
3
Oncology & Cancer
Researchers identify genetic drivers of most common form of lymphoma
Lymphoma is the most common blood cancer, but the diagnosis belies a wildly diverse and little understood genetic foundation for the disease that hampers successful treatment.
Oct 5, 2017
0
0
Oncology & Cancer
Adding drug to standard care may prolong lymphoma survival
(HealthDay)—Long-term treatment with the drug rituximab (Rituxan) may extend the lives of some patients with a rare form of blood cancer, a new clinical trial finds.
Sep 28, 2017
0
32
Oncology & Cancer
ART era has changed secondary cancers after Kaposi sarcoma
(HealthDay)—There has been a significant decline in the risk of secondary cancers after Kaposi sarcoma (KS) in the era of highly-active antiretroviral therapy (HAART), according to a study published online Aug. 24 in JAMA ...
Aug 25, 2017
0
1
Oncology & Cancer
Experimental drug trial seeks to improve treatment for lymphoma
Patients with a common type of fast-growing cancer are being given fresh hope in a new clinical trial.
Aug 11, 2017
0
4
Oncology & Cancer
Breakthrough in reversing treatment resistance in blood cancer patients
Researchers from the University of Southampton have identified why some people may become resistant to monoclonal antibodies, a common type of immunotherapy used in lymphoma treatment.
Jul 14, 2017
0
1
Oncology & Cancer
Cancer researchers look at resistance to targeted therapy in mantle cell lymphoma
Today some patients suffering with mantle cell lymphoma, a type of blood cancer, can be treated with a pill called Ibrutinib, forgoing conventional chemotherapy. However, many are developing a resistance to this treatment. ...
Jun 14, 2017
0
18
Oncology & Cancer
Hodgkin lymphoma survivors at high risk of second cancers
Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports.
Mar 13, 2017
0
0
